Hwail Pharmaceutical Co.,Ltd. (KOSDAQ: 061250)

Market Cap	112.43B
Revenue (ttm)	107.87B
Net Income (ttm)	1.92B
Shares Out	75.36M
EPS (ttm)	47.45
PE Ratio	31.44
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	524,314
Open	1,508.00
Previous Close	1,511.00
Day's Range	1,484.00 - 1,516.00
52-Week Range	1,400.00 - 2,365.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Hwail Pharmaceutical Co.,Ltd.

Hwail Pharmaceutical Co.,Ltd. develops pharmaceutical raw materials in South Korea. It provides raw drug products, finished drug products, and functional health food raw material business. The company was founded in 1974 and is headquartered in Seongnam-si, South Korea.

• Industry: Pharmaceutical Preparations
• Founded: 1974
• Employees: 130
• Stock Exchange: KOSDAQ
• Ticker Symbol: 061250

Financial Performance

In 2016, Hwail Pharmaceutical Co.,Ltd.'s revenue was 111.52 billion, an increase of 5.08% compared to the previous year's 106.13 billion. Earnings were 6.38 billion, an increase of 17.03%.